コンテンツへスキップ
Merck

PHR1542

Supelco

モキシフロキサシン 塩酸塩

Pharmaceutical Secondary Standard; Certified Reference Material

別名:

1-シクロプロピル-6-フルオロ-8-メトキシ-7-[(4aS,7aS)-オクタヒドロピロロ[3,4-b]ピリジン-6-イル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸 塩酸塩

ログイン組織・契約価格を表示する


About This Item

実験式(ヒル表記法):
C21H24FN3O4· HCl
CAS番号:
分子量:
437.89
Beilstein:
8377447
MDL番号:
UNSPSCコード:
41116107
PubChem Substance ID:
NACRES:
NA.24

グレード

certified reference material
pharmaceutical secondary standard

品質水準

認証

traceable to Ph. Eur. Y0000703
traceable to USP 1448606

APIファミリー

moxifloxacin

CofA

current certificate can be downloaded

包装

pkg of 1 g

テクニック

HPLC: suitable
gas chromatography (GC): suitable

アプリケーション

pharmaceutical (small molecule)

フォーマット

neat

保管温度

2-30°C

SMILES記法

Cl.COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(O)=O

InChI

1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1

InChI Key

IDIIJJHBXUESQI-DFIJPDEKSA-N

類似した製品をお探しですか? 訪問 製品比較ガイド

詳細

Moxifloxacin Hydrochloride is an anti-infectious compound that belongs to the class of fluoroquinolone antibiotics. It is a well-known broad-spectrum antibiotic prescription medicine effective against a variety of Gram-positive and Gram-negative bacteria including the anaerobic type. It is an S,S-isomer with two chiral centers. It works by preventing the activity of various crucial enzymes involved in the replication, transcription, recombination, and repair of deoxyribonucleic acid in the bacteria such as DNA gyrase (topoisomerase II), topoisomerase IV. It finds its application in the treatment of various ocular and respiratory tract infections.
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

アプリケーション

Moxifloxacin Hydrochloride can be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations and combined dosage forms by spectrophotometric, chromatographic, and electrochemical techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

アナリシスノート

このような2次標準は、入手可能な場合にはUSP、EP、BPの1次標準にマルチトレーサビリティを提供します。

その他情報

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

脚注

To see an example of a Certificate of Analysis for this material enter LRAC0258 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

ピクトグラム

Exclamation mark

シグナルワード

Warning

危険有害性情報

危険有害性の分類

Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Irrit. 2

保管分類コード

11 - Combustible Solids

WGK

WGK 2

引火点(°F)

Not applicable

引火点(℃)

Not applicable


最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

適切なバージョンが見つかりませんか。

特定のバージョンが必要な場合は、ロット番号またはバッチ番号で特定の証明書を検索できます。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

この製品を見ている人はこちらもチェック

Development and validation of spectrophotometric, atomic absorption and kinetic methods for determination of moxifloxacin hydrochloride
Abdellaziz LM and Hosny MM
Analytical Chemistry Insights, 6(3), ACI-S8090 (2011)
Electrochemical determination of antibacterial drug moxifloxacin hydrochloride using chloranil modified carbon paste electrode
Attia AK and El-Shal MA
Analytical and Bioanalytical Chemistry, 4(3), 213-224 (2012)
Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations
Motwani SK, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 68(2), 250-256 (2007)
Enantiomeric purity assay of moxifloxacin hydrochloride by capillary electrophoresis
Cruz LA and Hall R
Journal of Pharmaceutical and Biomedical Analysis, 38(1), 8-13 (2005)
Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
Miller D
Clinical Ophthalmology (Auckland, N.Z.), 2(1), 77-77 (2008)

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)